TGFB1 and cancer: These effects of TGFβ were linked to a direct inhibition of mTOR-dependent metabolic activity in NK cells stimulated by IL-15, and point to the stimulation of NK cell metabolic activity as a potential strategy to promote or enhance NK cell-based cancer therapies.